X- linked recessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Widely spaced teeth
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
West Syndrome
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
West Syndrome
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality.
|
24357517 |
2014 |
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Upward slant of palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Upper limb spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tumor Progression
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The Phosphatidylinositol glycan class A (PIG-A) gene mutation assay phenotypically measures erythrocyte mutations, assessed here for their correlation to neoplastic progression in the gastro-oesophageal reflux disease (GORD)-Barrett's metaplasia (BM)-oesophageal adenocarcinoma (OAC) model.
|
30914682 |
2019 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Basically, the molecular events which underlie the complexity of the syndrome consist of the absence of the glycosylphosphatidylinositol (GPI) anchor as a consequence of somatic mutations in the PIG-A gene, located on the X chromosome.
|
11378665 |
2001 |
Triangular mouth
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Transient Ischemic Attack
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Thrombotic Microangiopathies
|
0.010 |
Biomarker
|
group |
BEFREE |
Serum from patients with aHUS resulted in a significant increase of nonviable PIGA-deficient TF-1 cells compared with serum from healthy controls (P < .001) and other TMAs (P < .001).
|
25862562 |
2015 |
Thrombophilia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Spasticity, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Somatic mutation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A recurrent germline mutation in the PIGA gene causes Simpson-Golabi-Behmel syndrome type 2.
|
26545172 |
2016 |
Short neck
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Hypomorphic germline mutations in the PIGA (phosphatidylinositol glycan class A) gene recently were recognized as the cause of a clinically heterogeneous spectrum of X-linked disorders including (i) early onset epileptic encephalopathy with severe muscular hypotonia, dysmorphism, multiple congenital anomalies, and early death ("MCAHS2"), (ii) neurodegenerative encephalopathy with systemic iron overload (ferro-cerebro-cutaneous syndrome, "FCCS"), and (iii) intellectual disability and seizures without dysmorphism.
|
26545172 |
2016 |
Pulmonary Embolism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pulmonary arterial hypertension
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Protein Deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk<sup>+/-</sup> cells and the CD90.2 antigen.
|
29115020 |
2018 |
Protein Deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Although a single mutation event in the X-chromosomal gene PIGA is known to cause GPI-anchored protein deficiency, 2 such hits are required in the autosomal gene PIGT.
|
23733340 |
2013 |
Prominent occiput
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Primary malignant neoplasm
|
0.020 |
GeneticVariation
|
group |
BEFREE |
In this study, we investigated whether mutation of the PIGA gene could be exploited to identify mutator (Mut) phenotypes in cancer.
|
11212264 |
2001 |